Organization · Venture Capital
Solasta Ventures
Solasta Ventures is a Boston-based venture capital firm focused on investing in innovative life sciences companies that address unmet medical needs. As a subsidiary of Aju IB Investment, it leverages scientific expertise and a global network to identify transformative therapeutics.
Overview
What Solasta Ventures does
What Solasta Ventures is
Solasta Ventures is a Boston-based venture capital firm focused on investing in innovative life sciences companies that address unmet medical needs. As a subsidiary of Aju IB Investment, it leverages scientific expertise and a global network to identify transformative therapeutics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 10, 2026
Official channels
Find Solasta Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Solasta Ventures as a funder
Investment thesis
Invests in innovative companies with novel science advancing standard of care for diseases with unmet medical needs. Focus on US-based life science companies and early-stage startups.
Focus narrative
Solasta Ventures invests in the life sciences sector, specifically targeting therapeutics and technologies that can transform patient care in both U.S. and global markets. The firm seeks to partner with strong management teams that can effectively utilize capital and prioritize assets for long-term value creation, while also looking for opportunities for partnerships and collaborations with global pharmaceutical companies.
Value beyond capital
Solasta Ventures adds value to its portfolio companies by leveraging deep scientific expertise and an extensive network, particularly through connections within the South Korean pharmaceutical ecosystem. The firm actively engages with its portfolio companies, providing strategic guidance and support for growth.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 26
- Recorded notable exits
- company names
Portfolio context
Notable portfolio companies include: Arcellx: Focused on cell therapy. Carbon Biosciences: A biotech company. EvolveImmune Therapeutics: Specializes in immunotherapy. Trefoil Therapeutics: Works in ophthalmology and corneal disease.
Common questions
What to know about Solasta Ventures
Upseed classifies Solasta Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.